Literature DB >> 24882208

E-cadherin couples death receptors to the cytoskeleton to regulate apoptosis.

Min Lu1, Scot Marsters1, Xiaofen Ye1, Elizabeth Luis2, Lino Gonzalez2, Avi Ashkenazi3.   

Abstract

Epithelial-to-mesenchymal transition (EMT) is a cellular process essential to the development and maintenance of solid tissues. In cancer, EMT suppresses apoptosis, but the mechanisms remain unclear. EMT selectively attenuated apoptosis signaling via the death receptors DR4 and DR5. Loss of the epithelial cell adhesion protein E-cadherin recapitulated this outcome, whereas homotypic E-cadherin engagement promoted apoptotic signaling via DR4/DR5, but not Fas. Depletion of α-catenin, which couples E-cadherin to the actin cytoskeleton, or actin polymerization inhibitors similarly attenuated DR4/DR5-induced apoptosis. E-cadherin bound specifically to ligated DR4/DR5, requiring extracellular cadherin domain 1 and calcium. E-cadherin augmented DR4/DR5 clustering and assembly of the death-inducing signaling complex (DISC), increasing caspase-8 activation in high molecular weight cell fractions. Conversely, EMT attenuated DR4/DR5-mediated DISC formation and caspase-8 stimulation. Consistent with these findings, epithelial cancer cell lines expressing higher E-cadherin levels displayed greater sensitivity to DR4/DR5-mediated apoptosis. These results have potential implications for tissue homeostasis as well as cancer therapy.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24882208     DOI: 10.1016/j.molcel.2014.04.029

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  41 in total

1.  The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl.

Authors:  Jennifer L Dine; Ciara C O'Sullivan; Donna Voeller; Yoshimi E Greer; Kathryn J Chavez; Catherine M Conway; Sarah Sinclair; Brandon Stone; Laleh Amiri-Kordestani; Anand S Merchant; Stephen M Hewitt; Seth M Steinberg; Sandra M Swain; Stanley Lipkowitz
Journal:  Breast Cancer Res Treat       Date:  2016-01-12       Impact factor: 4.872

2.  ML327 induces apoptosis and sensitizes Ewing sarcoma cells to TNF-related apoptosis-inducing ligand.

Authors:  Eric J Rellinger; Chandrasekhar Padmanabhan; Jingbo Qiao; Andrew Appert; Alex G Waterson; Craig W Lindsley; R Daniel Beauchamp; Dai H Chung
Journal:  Biochem Biophys Res Commun       Date:  2017-07-14       Impact factor: 3.575

Review 3.  Targeting the extrinsic apoptotic pathway in cancer: lessons learned and future directions.

Authors:  Avi Ashkenazi
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

Review 4.  Nuclear signaling from cadherin adhesion complexes.

Authors:  Pierre D McCrea; Meghan T Maher; Cara J Gottardi
Journal:  Curr Top Dev Biol       Date:  2015-02-12       Impact factor: 4.897

5.  Regulation of death receptor signaling by the autophagy protein TP53INP2.

Authors:  Saška Ivanova; Mira Polajnar; Alvaro Jesus Narbona-Perez; Maria Isabel Hernandez-Alvarez; Petra Frager; Konstantin Slobodnyuk; Natalia Plana; Angel R Nebreda; Manuel Palacin; Roger R Gomis; Christian Behrends; Antonio Zorzano
Journal:  EMBO J       Date:  2019-04-12       Impact factor: 11.598

6.  From Proteomic Mapping to Invasion-Metastasis-Cascade Systemic Biomarkering and Targeted Drugging of Mutant BRAF-Dependent Human Cutaneous Melanomagenesis.

Authors:  Aikaterini F Giannopoulou; Athanassios D Velentzas; Athanasios K Anagnostopoulos; Adamantia Agalou; Nikos C Papandreou; Stamatia A Katarachia; Dimitra G Koumoundourou; Eumorphia G Konstantakou; Vasiliki I Pantazopoulou; Anastasios Delis; Maria T Michailidi; Dimitrios Valakos; Dimitris Chatzopoulos; Popi Syntichaki; Vassiliki A Iconomidou; Ourania E Tsitsilonis; Issidora S Papassideri; Gerassimos E Voutsinas; Polydefkis Hatzopoulos; Dimitris Thanos; Dimitris Beis; Ema Anastasiadou; George Th Tsangaris; Dimitrios J Stravopodis
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

Review 7.  Cadherins: cellular adhesive molecules serving as signalling mediators.

Authors:  Mark Yulis; Dennis H M Kusters; Asma Nusrat
Journal:  J Physiol       Date:  2018-08-08       Impact factor: 5.182

8.  First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer.

Authors:  Joshua M Abbott; Qiong Zhou; Hector Esquer; Laura Pike; Travis P Broneske; Sébastien Rinaldetti; Adedoyin D Abraham; Dominique A Ramirez; Paul J Lunghofer; Todd M Pitts; Daniel P Regan; Aik Choon Tan; Daniel L Gustafson; Wells A Messersmith; Daniel V LaBarbera
Journal:  Mol Cancer Ther       Date:  2020-06-04       Impact factor: 6.261

9.  Combination therapy induces unfolded protein response and cytoskeletal rearrangement leading to mitochondrial apoptosis in prostate cancer.

Authors:  Sandeep Kumar; Ajay K Chaudhary; Rahul Kumar; Jordan O'Malley; Anna Dubrovska; Xinjiang Wang; Neelu Yadav; David W Goodrich; Dhyan Chandra
Journal:  Mol Oncol       Date:  2016-03-31       Impact factor: 6.603

10.  Loss of α(E)-catenin promotes Fas mediated apoptosis in tubular epithelial cells.

Authors:  Xinhui Wang; Alan R Parrish
Journal:  Apoptosis       Date:  2015-07       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.